Medication abortion is a safe and effective method of pregnancy termination which now accounts for more than 60% of abortions in the US. Although prior studies have examined patient experiences and acceptability of medication abortion, most have focused on pregnancies under 77 days’ gestation. The limited qualitative research on medication abortion at later gestational durations has primarily examined those that are in the latter half of the second trimester and has largely been conducted outside the US. As a result, there is little peer-reviewed evidence describing patient experiences with medication abortion during the late first trimester to the early second trimester, particularly in US outpatient settings. Our proposed study addresses this critical gap by generating qualitative evidence on patient experiences with medication abortion between 78 and 97 days’ gestation. Using an interview-based qualitative study design, we seek to understand patients’ experiences undergoing medication abortion at later gestational durations. Findings from this study will inform patient-centered improvements in clinical care delivery for medication abortion. Specifically, we will develop an evidence-based clinical toolkit that includes best-practice recommendations, sample patient education materials, and guidance for clinicians providing care in outpatient settings. We also plan to translate study findings into accessible, patient-oriented resources to better support individuals who are pregnant or may become pregnant.